Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma.

Shen DY, Zhang W, Zeng X, Liu CQ.

Cancer Sci. 2013 Oct;104(10):1303-8. doi: 10.1111/cas.12223. Epub 2013 Aug 6.

2.

β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.

Huang GL, Shen DY, Cai CF, Zhang QY, Ren HY, Chen QX.

World J Gastroenterol. 2015 Jan 28;21(4):1148-57. doi: 10.3748/wjg.v21.i4.1148.

3.

Oncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.

Huang GL, Luo Q, Rui G, Zhang W, Zhang QY, Chen QX, Shen DY.

Mol Cell Biol. 2013 Sep;33(17):3416-25. doi: 10.1128/MCB.00384-13. Epub 2013 Jun 24.

4.

Tamoxifen reverses the multi-drug-resistance of an established human cholangiocarcinoma cell line in combined chemotherapeutics.

Liu ZH, Ma YL, He YP, Zhang P, Zhou YK, Qin H.

Mol Biol Rep. 2011 Mar;38(3):1769-75. doi: 10.1007/s11033-010-0291-z. Epub 2010 Sep 14.

PMID:
20835928
5.

Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.

Zhang KS, Zhou Q, Wang YF, Liang LJ.

Oncol Rep. 2013 Sep;30(3):1430-8. doi: 10.3892/or.2013.2560. Epub 2013 Jun 21.

PMID:
23799613
6.

Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells.

Loilome W, Bungkanjana P, Techasen A, Namwat N, Yongvanit P, Puapairoj A, Khuntikeo N, Riggins GJ.

Tumour Biol. 2014 Jun;35(6):5357-67. doi: 10.1007/s13277-014-1698-2. Epub 2014 Feb 19.

7.
8.

Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway.

Zhang H, Zhang X, Wu X, Li W, Su P, Cheng H, Xiang L, Gao P, Zhou G.

Cancer Lett. 2012 Oct 1;323(1):106-13. doi: 10.1016/j.canlet.2012.03.039. Epub 2012 Apr 4.

PMID:
22484497
9.

MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.

Chen Z, Ma T, Huang C, Zhang L, Lv X, Xu T, Hu T, Li J.

Cell Signal. 2013 Dec;25(12):2693-701. doi: 10.1016/j.cellsig.2013.08.032. Epub 2013 Sep 7.

PMID:
24018051
10.

Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways.

Huang GL, Zhang W, Ren HY, Shen XY, Chen QX, Shen DY.

Cancer Sci. 2015 Nov;106(11):1515-23. doi: 10.1111/cas.12802. Epub 2015 Oct 7.

11.

Establishment and identification of the human multi-drug-resistant cholangiocarcinoma cell line QBC939/ADM.

Liu ZH, He YP, Zhou Y, Zhang P, Qin H.

Mol Biol Rep. 2011 Jun;38(5):3075-82. doi: 10.1007/s11033-010-9975-7. Epub 2010 Jan 29.

PMID:
20111907
12.

Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.

Gao Y, Liu Z, Zhang X, He J, Pan Y, Hao F, Xie L, Li Q, Qiu X, Wang E.

Cancer Lett. 2013 Aug 9;336(1):231-9. doi: 10.1016/j.canlet.2013.05.005. Epub 2013 May 11.

PMID:
23673211
13.

Inhibition of transient receptor potential channel 5 reverses 5-Fluorouracil resistance in human colorectal cancer cells.

Wang T, Chen Z, Zhu Y, Pan Q, Liu Y, Qi X, Jin L, Jin J, Ma X, Hua D.

J Biol Chem. 2015 Jan 2;290(1):448-56. doi: 10.1074/jbc.M114.590364. Epub 2014 Nov 17.

14.

NK4 regulates 5-fluorouracil sensitivity in cholangiocarcinoma cells by modulating the intrinsic apoptosis pathway.

Ge X, Wang Y, Li Q, Yu H, Ji G, Miao L.

Oncol Rep. 2013 Jul;30(1):448-54. doi: 10.3892/or.2013.2427. Epub 2013 Apr 25.

PMID:
23619566
15.

The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.

Flahaut M, Meier R, Coulon A, Nardou KA, Niggli FK, Martinet D, Beckmann JS, Joseph JM, Mühlethaler-Mottet A, Gross N.

Oncogene. 2009 Jun 11;28(23):2245-56. doi: 10.1038/onc.2009.80. Epub 2009 May 4.

PMID:
19421142
16.

Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma.

Tan XY, Chang S, Liu W, Tang HH.

Gut Liver. 2014 Mar;8(2):196-204. doi: 10.5009/gnl.2014.8.2.196. Epub 2013 Nov 5.

17.

Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.

Wu WR, Zhang R, Shi XD, Zhu MS, Xu LB, Zeng H, Liu C.

Oncol Rep. 2014 Jun;31(6):2515-24. doi: 10.3892/or.2014.3123. Epub 2014 Apr 2.

PMID:
24700253
18.

Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.

Zheng T, Hong X, Wang J, Pei T, Liang Y, Yin D, Song R, Song X, Lu Z, Qi S, Liu J, Sun B, Xie C, Pan S, Li Y, Luo X, Li S, Fang X, Bhatta N, Jiang H, Liu L.

Hepatology. 2014 Mar;59(3):935-46. doi: 10.1002/hep.26705. Epub 2014 Jan 29.

PMID:
24037855
19.

Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.

Obchoei S, Weakley SM, Wongkham S, Wongkham C, Sawanyawisuth K, Yao Q, Chen C.

Mol Cancer. 2011 Aug 26;10:102. doi: 10.1186/1476-4598-10-102.

20.

Mucins 1-shRNA inhibit the proliferation and HIF-1alpha protein expression on human cholangiocarcinoma cells.

Li ZR, Wei JL, Li ZZ, Li SF.

Cell Biol Int. 2013 Feb;37(2):121-5. doi: 10.1002/cbin.10020.

PMID:
23339102
Items per page

Supplemental Content

Write to the Help Desk